# Conversion to Monotherapy Study With Keppra XR for Partial Seizures

> **NCT00419094** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 228 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Keppra XR
- **DRUG:** Keppra XR

## Key facts

- **NCT ID:** NCT00419094
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2014-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419094, "Conversion to Monotherapy Study With Keppra XR for Partial Seizures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00419094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*